Scholarlink

Background <p>Coronary artery disease (CAD) is a&#xa0;leading cause of morbidity and mortality worldwide, affecting both women and men. However, its evaluation and treatment have historically been influenced by gender, resulting in significant disparities for women.</p> Objective <p>This review aims to comprehensively examine the literature on gender disparities in the care of patients with CAD.</p> Results <p>Evidence highlights several key inequalities, including the relatively greater impact of shared risk factors in women, the presence of female-specific risk factors, differences in CAD symptom presentation, and reduced screening sensitivity and management quality in women compared with men.</p> Conclusions <p>Addressing these disparities requires updated screening strategies that recognize the unique clinical manifestations of CAD in women, increasing awareness among both women and healthcare providers, greater inclusion of women in CAD research studies, revisiting the role of hormonal replacement therapy, and integrating emerging tools such as genetic research and artificial intelligence. These steps have the potential to improve the equity and effectiveness of CAD management across genders.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Gender disparities in coronary artery disease: a review of factors influencing clinical outcomes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月10日

查看全文
  • Arsalan Siddiqui,
  • Randeep Gill,
  • Marc Ringor,
  • Jasmine K. Dugal,
  • Arpinder Malhi,
  • Ala Abdallah,
  • Dalia Hawwass,
  • Nazanin Houshmand,
  • Tahir Tak

摘要

Background

Coronary artery disease (CAD) is a leading cause of morbidity and mortality worldwide, affecting both women and men. However, its evaluation and treatment have historically been influenced by gender, resulting in significant disparities for women.

Objective

This review aims to comprehensively examine the literature on gender disparities in the care of patients with CAD.

Results

Evidence highlights several key inequalities, including the relatively greater impact of shared risk factors in women, the presence of female-specific risk factors, differences in CAD symptom presentation, and reduced screening sensitivity and management quality in women compared with men.

Conclusions

Addressing these disparities requires updated screening strategies that recognize the unique clinical manifestations of CAD in women, increasing awareness among both women and healthcare providers, greater inclusion of women in CAD research studies, revisiting the role of hormonal replacement therapy, and integrating emerging tools such as genetic research and artificial intelligence. These steps have the potential to improve the equity and effectiveness of CAD management across genders.